Press Releases
Search
-
10 Dec 2007
bioMérieux to Gradually Close its Boxtel Site in the Netherlands
Marcy l’Etoile, France - December 10, 2007 . bioMérieux (Euronext: BIM) announced that it will phase out activities at its Boxtel site in the Netherlands by the end of 2009. The site develops and manu...
-
08 Nov 2007
bioMérieux, First In Vitro Diagnostics Company to Open a Subsidiary in Algeria
November 8, 2007 . bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, has announced its plans to open a subsidiary in Algeria in early 2008. The new subsidiary, based in ...
-
07 Nov 2007
bioMérieux launches TEMPO® EB, the first automated test for Enterobacteriaceae enumeration in food products
Marcy l'Etoile, France - November 7, 2006. Marcy l’Etoile, France – November 7, 2006 : bioMérieux launches TEMPO® EB, the first automated test for Enterobacteriaceae enumeration in food products in 24...
-
26 Oct 2007
Business Review for the nine months ended September 30, 2007 Nine-month sales up 6.9% like-for-like
Marcy l'Etoile, France - October 26, 2007. bioMérieux (Euronext: BIM), a global leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, ...
-
18 Oct 2007
FDA Clears bioMérieux’s VIDAS® B·R·A·H·M·S PCT® Assay A First Indication for Sepsis Risk Assessment in the ICU
Marcy l’Etoile (France) - Oct. 18, 2007. bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration to ma...
-
08 Oct 2007
bioMérieux and Compliance Software Solutions Corp. Partner to Enhance Data Management for the Pharmaceutical Industry
Marcy l’Etoile (France) - Oct. 8, 2007. bioMérieux, a leading industrial microbiology and in vitro diagnostics company, has signed an exclusive global sales representative agreement with Compliance So...
-
01 Oct 2007
bioMérieux Launches VIDAS® NT-proBNP, an Aid for Diagnosis and Prognosis of Heart Failure
Marcy l’Etoile (France) - October 1, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, announces the launch of VIDAS® NT-proBNP, a CE-approved test that helps the diagnosis and p...
-
27 Sep 2007
Early Diagnosis of Sepsis: bioMérieux presents new Sepsis Handbook at International Sepsis Forum
Marcy l’Etoile (France) - Sept. 26, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, today announces the launch of the “Sepsis Handbook”. This comprehensive book, produced by bi...
-
17 Sep 2007
First–Half 2007 Financial Results Sales up 6.7% like-for-like
Marcy l'Etoile, France - Sept. 17, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its results for the six months ended June 30, 2007. - First–Half 2007 Financi...
-
17 Sep 2007
bioMérieux and Ipsen Sign Theragnostics Agreement to Develop Companion Test for New Breast Cancer Treatment
Marcy l’Étoile and Paris (France) - Sept. 17, 2007. bioMérieux and Ipsen announce today that they have signed an agreement by which bioMérieux will develop a companion test for a new breast cancer dru...
-
12 Sep 2007
bioMérieux Acquires the Australian BTF, Strengthening its Leadership Position in Industrial Microbiology
Marcy l'Etoile, France - September 12, 2007. As world leader in the field of industrial microbiology, bioMérieux (Euronext: BIM) will bring solutions integrating BTF’s innovative technology to a wide ...
-
06 Sep 2007
bioMérieux, première entreprise en Rhône-Alpes à obtenir des Certificats d’économies d’énergie
Marcy l'Etoile, France - September 6, 2007. bioMérieux S.A. (Euronext : BIM) a été certifié par la DRIRE pour des opérations d’économies d’énergie. bioMérieux est ainsi l’une des premières entreprises...
-
08 Aug 2007
Accord transactionnel entre bioMérieux et Becton, Dickinson dans le domaine de la détection des staphylocoques dorés résistants à la méthicilline
Marcy l'Etoile, France - August 8, 2007 . bioMérieux S.A. (Euronext: BIM) announced today that it has concluded a settlement on several licence agreements with GeneOhm Sciences Canada, a subsidiary of...
-
27 Jul 2007
First–Half 2007 - Sales Up 6.7% Like-For-Like
Marcy l'Etoile, France - July 27, 2007. bioMérieux (Euronext: BIM), a global leader in the field of in vitro diagnostics, today released its business review for the first six months of 2007. Because t...
-
24 Jul 2007
bioMérieux lance le premier test automatisé de détection des toxines A et B de Clostridium difficile
July 24, 2007. A new, rapid, and effective solution in the fight against hospital-acquired (nosocomial)infections. bioMérieux, a world leader in the field of in vitro diagnostics, (Euronext : BIM) has...